Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Hodgkin Disease 10Lymphoma 5Neoplasms, Germ Cell and Embryonal 3Seminoma 2Vulvar Neoplasms 1Testicular Neoplasms 1Teratoma 1Neoplasms, Second Primary 1Neoplasms 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Hemangioma, Capillary 1Endodermal Sinus Tumor 1Desmoid Tumors 1Carcinoma, Embryonal 1

Interventions

pembrolizumab 4aldesleukin 3Cisplatin 3lenvatinib 2Surveys and Questionnaires 2Specimen Handling 2Paclitaxel 2Nivolumab 2Magnetic Resonance Spectroscopy 2Adoptive Transfer 2zimberelimab 1trastuzumab deruxtecan 1tivozanib 1liposomal doxorubicin 1fludarabine phosphate 1fludarabine 1entinostat 1dostarlimab 1cemiplimab 1bintrafusp alfa protein, human 1belzutifan 1atezolizumab 1Therapeutic Touch 1Taxes 1Standard of Care 1Sonazoid 1Respiratory Function Tests 1Radiotherapy 1Radiation 1Prochlorperazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vulvar Neoplasms × Bleomycin × 1 year × Clear all
NCT06715592 2025-08-08

ECT STUDY High-grade or Initially Invasive Vulva - GinOnc-ECT Study

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 2 Active not recruiting
18 enrolled
Gynecologic

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡